The Atlanta homebuilder logged net income of $913.2 million, or $4.43 a share, compared to about $711 million, or $3.28 a share, a year earlier. Analysts polled by FactSet expected $3.26 a share.
Quest Diagnostics' fourth-quarter net income and revenue rose beyond Wall Street expectations, and the medical firm forecast more growth in 2025 amid rising demand for its health-care tests.